Monthly Archives: April 2010
Beverly Motsch-Bantel
My mother Beverly was a dancer, singer, homemaker, devout Christian and amazing mother. She gave up a career in dance and married, and then devoted her life to raising me and my sister, as well as two stepchildren. She was … Continue reading
Posted in Mothers We Love, Personal stories Leave a comment
Rachel Zoe & the Alliance featured in InStyle magazine!
An interview with celebrity stylist and fashion icon Rachel Zoe is featured in the April issue of InStyle magazine, where Rachel highlights the event she hosted for the Ovarian Cancer National Alliance at Decades Two in Los Angeles. The accessory … Continue reading
AstraZeneca drug shows promise in ovarian cancer
An experimental drug from AstraZeneca that blocks a cell repair enzyme known as PARP has shown promise as a treatment for ovarian cancer, as well as breast cancer, researchers said on Monday. Olaparib shrank or stabilized tumors in around half … Continue reading
Florence Shockley
My mom was diagnosed with stage IV ovarian cancer in January of 2006. She endured a major surgery and months of chemotherapy and complications. But the cancer had spread to her lungs and brain. She fought hard and wanted so … Continue reading
Posted in Mothers We Love, Personal stories Leave a comment
Improving the Efficiency of Clinical Trials: Decreasing Activation Times by Fifty Percent (NCI)
NCI is dedicated to bringing new therapeutic and diagnostic options to patients with cancer as quickly as possible. On average, 25,000 to 30,000 patients per year are accrued to NCI-supported clinical trials through several networks of institutions and clinical trialists. … Continue reading
Phase II study of liposomal cisplatin (SPI-77) in platinum-sensitive recurrences of ovarian cancer
BACKGROUND: Cisplatin is a highly effective chemotherapeutic agent against epithelial ovarian cancer but is associated with significant toxicities. SPI-77 is a liposomal pegylated formulation of cisplatin that was developed to reduce systemic toxicity and to better deliver cisplatin to tumors. … Continue reading
Trastuzumab sensitizes ovarian cancer cells to EGFR-targeted therapeutics
BACKGROUND: Early studies have demonstrated comparable levels of HER2/ErbB2 expression in both breast and ovarian cancer. Trastuzumab (Herceptin), a therapeutic monoclonal antibody directed against HER2, is FDA-approved for the treatment of both early and late stage breast cancer. However, clinical … Continue reading
Doxie Smentkowski
My story is somewhat different, I am a 5 year survivor of stage 3c ovarian cancer. I was diagnosed with breast cancer when I was 26 years old, melanoma when I was 40 and ovarian when I was 51. My … Continue reading
Posted in Mothers We Love, Personal stories Leave a comment
Linda Butler
My name is Valarie Butler, I am the 31 year old daughter to a woman, who while on this earth, was cherished by so many and to who I admire and respect more than anyone I will ever know. That … Continue reading
Posted in Mothers We Love, Personal stories Leave a comment
